KMT2A and myeloid neoplasm: Therapy-related myeloid neoplasms [241], infant leukemia associated with mixed-lineage leukemia (MLL) gene rearrangements [242], and a subtype of de novo acute myeloid leukemia [243], have low NQO1 activity.